Immix Biopharma Inc

Company

11400 West Olympic Blvd, Suite 200
90064 Los Angeles
United States

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases. Our lead cell therapy is FDA IND cleared next generation CAR-T NXC-201, currently being evaluated in our ongoing Phase 1b/2 NEXICART-1 (NCT04720313) clinical trial, initiated in February 2021. NXC-201 has the potential to be the world’s first “Single-Day CRS” CAR-T (CRS median onset day 1, median duration 1 day), enabling the potential for a faster return home for patients and supporting ongoing expansion into autoimmune indications. NXC-201 has been awarded Orphan Drug Designation (ODD) by the FDA in both AL Amyloidosis and multiple myeloma, and ODD by the European Commission (EMA) in AL Amyloidosis.

(310) 651-8041
https://immixbio.com/
Mon – Fri: 8am – 5pm PST.

Schreiben Sie einen Kommentar

Weiteres im Umkreis

• 

  West Jordan Porta Potty Rentals
  Rentals
  
  
• 

  Master Flow Heating & Air Conditioning INC
  HVAC Contractor
  92028 Fallbrook
  
• 

  First Call Painting
  painting contractor,
  
  
• 

  Med & Beauty Spa by Eve
  Beauty Spa
  
  
• 

  Oak Park Porta Potty Rentals
  Rentals
  
  
• 

  Best Injury Attorneys Los Angeles
  Law
  90036 Los Angeles
  
• 

  Reno Porta Potty Rentals
  Rentals
  
  
• Sandy Porta Potty Rentals
  Rentals
  
  
• 

  B&E Site Services
  Dumpster Rental
  77437 El Campo, TX
  
• 

  Pro Snow Solutions - Langley Snow Removal
  Snow Removal
  V3A 4B3 Langley, BC
  
• 

  WIEL Filmproduktion Leipzig
  Filmproduktion
  04315 Leipzig
  
• 

  ZUMA – Architekt Kielce – Biuro Projektowe Kielce – Wniosek O Warunki Zabudowy Kielce
  Architekt
  
  
• 

  Tokyo Narita airport - Delta Airlines
  Local business
  144-0041 Narita-shi
  
• 

  Pixie Stick Store
  Store
  
  
• 

  Radisson Hotel Curitiba
  Hotel
  80240-000 Curitiba, PR
  
• 

  Outdoor Insurance
  Insurance
  4551 Caloundra